Psoria-Shield, Inc. Announces Dr. Steven Feldman as Scientific Advisor

SCHAUMBURG, IL--(Marketwired - Jan 12, 2016) - Wellness Center USA, Inc. (OTCQB: WCUI) today announced that its wholly owned subsidiary, Psoria-Shield, Inc. (PSI), has engaged Dr. Steven Feldman, M.D., PhD as Scientific Advisor. Dr. Feldman is a Professor of Dermatology, Professor of Pathology, and Professor of Public Health Sciences - Social Science and Health Policy at Wake Forest Baptist Health.

Dr. Feldman directs the Center for Dermatology Research, a health services research center dedicated to improving the care of patients with skin disease. His chief clinical interest is psoriasis. He has served as a member of the medical board of the National Psoriasis Foundation, chaired that board's subcommittee on education, and served as the director of the Foundation's Chief Residents' Meeting on psoriasis treatment. He also chaired the American Academy of Dermatology's Psoriasis Education Initiative Workgroup, developing regional courses on emerging psoriasis therapies.

Dr. Feldman has published more than 500 articles in peer-reviewed journals and is a frequent speaker to lay groups, physicians, industry professionals, and managed care executives. He is editor and/or a member of the editorial board of five dermatology journals, has a regular column on patient adherence in PM360: The Essential Resource for Pharma Marketers, and is author of Practical Ways to Improve Patients' Treatment Outcomes and Compartments: How the Brightest, Best Trained, and Most Caring People Can Make Judgments That Are Completely and Utterly Wrong. He is also listed in Best Doctors in America.

"With Dr. Feldman's experience and insights, our ability to stay at the forefront of phototherapy going forward is greatly enhanced", said John Yorke, Managing Director of PDC. "With his knowledge we can advance this NASA legacy technology to its fullest potential for the benefit of patients and practitioners alike," he added.

In an ancillary agreement, PSI has placed a Psoria-Light (PL 1000) in Wake Forest Baptist for both photo-therapy patient treatments while supporting Dr. Feldman's clinical research in the area of photo-therapy.

About Wellness Center USA, Inc.
Wellness Center USA, Inc. (www.wellnesscenterusa.com) is a hybrid healthcare company that combines best in class technologies, software, devices, providers, protocols, goods, and services. It was created to address important healthcare and wellness needs via breakthrough solutions, all centered around the "well-being of the body and mind". Wellness Center USA, Inc. is the parent company of three businesses reporting consolidated: Stealth Mark, National Pain Centers, and Psoria-Shield.

Safe Harbor Statement:
Certain statements and projections contained in this presentation that are not statements or financial results of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements and projections include statements regarding any proposed exchange transactions, the anticipated closing date of such transactions and future results following a closing of the transactions. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like "believe," "expect," "anticipate," "pending", "estimate," and "intend" or future or conditional verbs such as "will," "would," "should," "could," or "may." While it is not possible to identify all factors, risks and uncertainties that might relate to, affect or arise from the proposed transactions and plans which might cause actual results to differ materially from expected results, such factors, risks and uncertainties include delays in completing the transactions, difficulties in integrating operations following the transactions, difficulties in manufacturing and delivering products, potential market rejection of products or services, increased competitive pressures, changes in general economic conditions, legislative and regulatory changes that adversely affect the business in which the parties are engaged, changes in the securities markets and other factors, risks and uncertainties disclosed from time to time in documents that the Company files with the SEC.